Recombinant Microbial Cell System for Alkane Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current whole-cell catalytic systems for producing terminal oxidation products of medium/long-chain alkanes face challenges such as overoxidation, product inhibition, and the need for additional inducers and medium changes, which increase costs and complexity.
Innovation Solution
A recombinant microbial cell system is developed that expresses a cytochrome P450 alkane monooxygenase, regulated by medium/long-chain alkanes or their fatty acid methyl esters, allowing for single-step growing cell culture biotransformation without additional inducers, using genetic engineering to activate gene expression and promote alkane oxidation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional whole-cell catalytic systems are used for alkane oxidation, then terminal oxidation products can be produced, but product overoxidation occurs and additional inducers are required
Solution Approach 1:
The patent divides the alkane oxidation pathway into two distinct enzymatic steps: (1) terminal oxidation catalyzed by alkane monooxygenase to produce primary alkanols, and (2) further oxidation prevention by using enzymes with specific selectivity. This segmentation allows control over the oxidation extent to avoid overoxidation to aldehydes and carboxylic acids.
Solution Approach 2:
The patent changes the biochemical parameters of the catalytic system by selecting specific enzyme systems (AlkB, CYP52, or CYP153) with different oxidation strengths and selectivities. By adjusting enzyme type, expression levels, and reaction conditions, the system achieves optimal production of terminal oxidation products while minimizing overoxidation.
2Reliability
If inducible enzyme expression systems are used, then enzyme activity can be controlled, but additional inducers and medium changes are required increasing complexity
Solution Approach 1:
The patent employs constitutive expression of alkane transporter genes and alkane monooxygenase genes, allowing the system to automatically respond to alkane presence without external inducers. The cells self-regulate enzyme production and alkane uptake based on substrate availability, eliminating the need for manual inducer addition and medium changes.
Solution Approach 2:
The patent pre-configures the recombinant microbial cells with constitutively expressed alkane transporters and alkane monooxygenases before substrate addition. This preliminary preparation ensures immediate enzyme activity upon alkane introduction, eliminating the lag time associated with inducer-dependent expression systems.
3Productivity
If AlkB system is used for alkane oxidation, then oxidation activity is achieved, but product inhibition occurs
Solution Approach 1:
The patent extracts and utilizes specific functional domains of the AlkB system (alkane monooxygenase activity) while separating it from components that cause product inhibition. By using purified enzyme systems or selectively expressing only the necessary genes, the system maintains oxidation activity while avoiding inhibitory effects from other system components.
Solution Approach 2:
The patent introduces redox partner proteins (rubredoxin and rubredoxin reductase) as intermediaries to facilitate electron transfer to alkane monooxygenase. These mediators enhance catalytic efficiency and reduce product inhibition by optimizing the redox environment and preventing accumulation of inhibitory intermediates.
4Productivity
If CYP52 system is used for alkane oxidation, then hydroxylation activity is achieved, but overoxidation to aldehydes and acids occurs
Solution Approach 1:
The patent dynamically adjusts the expression levels and activity of CYP52 enzymes based on substrate concentration and product accumulation. By using constitutive expression with regulated enzyme stability or activity, the system maintains optimal hydroxylation while preventing excessive oxidation that leads to aldehyde and carboxylic acid formation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces overoxidation, eliminates the need for inducers and medium changes, and enhances the regulation of CYP153A expression, resulting in a more efficient and environmentally friendly process for producing medium/long-chain alkane terminal oxidation products.
Implementation Method 1
The terminal oxidation products of medium/long-chain straight alkanes, such as medium/long-chain alkanediols and medium/long-chain alkanedioic acids, are widely applied in the industry
Implementation Method 2
whose first step in aerobic alkane decomposition is terminal oxidation of alkanes, which is catalyzed by alkane monooxygenases
Implementation Method 3
In an oxidation-reduction (redox) reaction, AlkB requires redox partner proteins, including rubredoxin and rubredoxin reductase as electron donors
Data Source
AI summary
Provided is a method of activating gene expression using a protein having 90% or more sequence identity to SEQ ID NO:45. The protein activates the expression of a gene upon induction with a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester. Also provided is a whole-cell catalytic system regulated by a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester. The system includes a recombinant microbial cell expressing the protein and an alkane monooxygenase. Also provided is a method of preparing a medium-chain or long-chain alkane terminal oxidation product using the whole-cell catalytic system.